← Back to category

Blood Electrification vs AIDS

Inventor: Steven Kaali & Paul Schwolsky
Device: Blood Electrifier
Folder: kaali
Original: Open article
Confidence
0.60
Practicability
0.40
Evidence
0.30
Fringe Score
0.70
Risk
0.50
TRL
3

Goal

Inactivate HIV virus in blood by applying low-voltage electric fields

Problem

HIV/AIDS infection

Concept Summary

Applying a low-voltage, low-current electrical potential (50-100 uA) to blood-either in a test tube, via an implantable electrode pair, or externally with a bi-phasic square-wave AC-disrupts the viral protein coating and prevents reverse-transcriptase activity, thereby rendering the virus non-infectious while leaving normal blood cells unharmed. The system may also include mechanical filtration of particles >0.2 um.

Principles

  • Low-voltage direct current
  • Low-current density (50-100 uA)
  • Bi-phasic square-wave AC (~=3.9 Hz)
  • Electric field forces (microwatt/milliwatt region)
  • Mechanical filtration (>0.2 um)
  • Resonant frequency disruption

Scientific Domains

Virology Biomedical Engineering Electrochemistry

Materials

  • Platinum electrodes
  • Glass tube (test tube)
  • Plastic housing for filter system

Mechanisms of Action

  • Disruption of viral outer protein coating
  • Inhibition of reverse transcriptase production
  • Electrostatic attenuation of virus particles
  • Mechanical removal of larger particles

Energy Sources

Low-voltage battery External power supply (AC source)

Applications

  • Therapeutic treatment of AIDS
  • Sterilization of blood and other body fluids

Claimed Performance

Practically all HIV viral particles were adversely affected while normal blood cells remained unharmed; a current of 50-100 uA produced the most effective results in vitro.

Experimental Evidence

Laboratory tests in 1990 showed inactivation of HIV-1 in a test tube when a 50-100 uA DC current was applied; the inventors filed a patent (US 5,139,684) describing the method. No peer-reviewed clinical data were presented.

Replication Status

Patent granted; no independent replication or clinical trials reported in the article.

Limitations

  • Requires precise current control (50-100 uA)
  • Implantable electrodes cause scarring and calcification
  • Lack of clinical trial data
  • Potential electrolysis with DC currents

Red Flags

  • Claims are based on anecdotal and unpublished laboratory data
  • No peer-reviewed studies or independent replication
  • Suppression allegations suggest possible bias

Keywords

HIV AIDS Blood electrification Low-current therapy Implantable electrode Bi-phasic square wave Virus inactivation

Related Technologies

Electrotherapy Plasma sterilization Blood filtration Medical device implants

📷 Images

0logo.gif
0logo.gif
5086-1.jpg
5086-1.jpg
5086-2.jpg
5086-2.jpg
8738-1.jpg
8738-1.jpg
8738-10.jpg
8738-10.jpg
8738-11.jpg
8738-11.jpg
8738-11a.jpg
8738-11a.jpg
8738-12.jpg
8738-12.jpg
8738-12a.jpg
8738-12a.jpg
8738-13.jpg
8738-13.jpg
8738-13a.jpg
8738-13a.jpg
8738-13b.jpg
8738-13b.jpg
8738-14.jpg
8738-14.jpg
8738-14a.jpg
8738-14a.jpg
8738-15-a.jpg
8738-15-a.jpg
8738-16.jpg
8738-16.jpg
8738-16a.jpg
8738-16a.jpg
8738-17.jpg
8738-17.jpg
8738-18.jpg
8738-18.jpg
8738-19.jpg
8738-19.jpg
8738-2.jpg
8738-2.jpg
8738-3.jpg
8738-3.jpg
8738-4.jpg
8738-4.jpg
8738-5.jpg
8738-5.jpg
8738-6.jpg
8738-6.jpg
8738-7.jpg
8738-7.jpg
8738-8.jpg
8738-8.jpg
8738-9.jpg
8738-9.jpg
appdx-e1.gif
appdx-e1.gif
appdx-e2.gif
appdx-e2.gif